Drug Trial Radar · NCT05637255
A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)
Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Nov 22, 2022
Primary completion
Dec 19, 2024
Study completion Dec 19, 2024
Sponsor
- Lead sponsor
- Sylentis, S.A.Industry
- Sponsor type
- Industry
- First posted
- Dec 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare the safety and effect on visual acuity of three different doses of SYL1801 eye drops.
Conditions
- Wet Macular Degeneration
- Neovascular Age-related Macular Degeneration
- Macular Degeneration
Interventions
SYL1801Drug
1 drop in the eligible eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline on visual acuity on Day 42 after last instillation of the assigned dose levelTime frame: 42 days after first administration
Locations
16 sites in 3 countries. Site status is shown where the registry gives one.
SYL1801 Investigative Site
Brno, Czechia
SYL1801 Investigative Site
Chomutov, Czechia
SYL1801 Investigative Site
Frýdek-Místek, Czechia
SYL1801 Investigative Site
Kyjov, Czechia
SYL1801 Investigative Site
Liberec, Czechia
SYL1801 Investigative Site
Ostrava, Czechia
SYL1801 Investigative Site
Prague, Czechia
SYL1801 Investigative Site
Prague, Czechia
SYL1801 Investigative Site
Gdansk, Poland
SYL1801 Investigative Site
Krakow, Poland
SYL1801 Investigative Site
Rzeszów, Poland
SYL1801 Investigative Site
Warsaw, Poland
SYL1801 Investigative Site
Bratislava, Slovakia
SYL1801 Investigative Site
Košice, Slovakia
SYL1801 Investigative Site
Poprad, Slovakia
SYL1801 Investigative Site
Žilina, Slovakia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.